Ross Levine, MD, PhD: Deep Dive on Acute Myeloid Leukemia

In this conversation, Daniel Belkin and Mitch Belkin interview Ross Levine, MD, PhD about Acute Myeloid Leukemia and its treatment. They discuss the different types of leukemias, the history of AML treatment, including chemotherapy and stem cell transplantation. They touch on Graft vs Host Disease, treatment after relapse, and open questions in leukemia, including future trials, and further investigation of ven/aza (Azacitidine/venetoclax).
00:03: Introduction
03:07: Leukemia Overview
04:19: Acute Myeloid Leukemia (AML)
08:00: History of Leukemia Treatment
11:25: Chemotherapy Regimens, Induction, Consolidation
16:30: Genetic subtypes of AML
19:55: Transplants
24:08: Graft v Host Disease
29:45: Relapse
31:58: Open Questions in Leukemia
35:15: What does your lab study?
36:17: The Future of AML treatment
37:53: Why is pediatric treatment of ALL so successful?
40:51: Rapidfire questions
Who is Ross Levine?
Dr. Ross Levine of the Memorial Sloan Kettering Cancer Center. Dr. Levine studies hematologic malignancies and is a world-renowned expert on myeloproliferative neoplasms and acute myeloid leukemia.
For more info:
Website: externalmedicinepodcast.com/r...
Subscribe: bit.ly/3Qia4md
Follow us on Twitter: bit.ly/3Vu3OKS
Consider donating: bit.ly/3rWPyge

[@user-px3kh6yx1k]

Great and honest doctor. I am so impressed!

[@KiKi70236]

I loved this. I have AML adverse risk and I am in hospice. Love learning about this disease.

[@dillydalie11]

I am aml with flt3 too. So basically I am terminal